← Evidence map

TrialNature medicine2025

Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.

Tarek K Rajji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40133524